These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 3143437

  • 21. Effects of long-term antihypertensive treatment on kidney function in diabetic nephropathy.
    Parving HH, Andersen AR, Hommel E, Smidt U.
    Hypertension; 1985; 7(6 Pt 2):II114-7. PubMed ID: 4077229
    [Abstract] [Full Text] [Related]

  • 22. Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy.
    Lacourcière Y, Bélanger A, Godin C, Hallé JP, Ross S, Wright N, Marion J.
    Kidney Int; 2000 Aug; 58(2):762-9. PubMed ID: 10916100
    [Abstract] [Full Text] [Related]

  • 23. Renal responses to nifedipine and captopril in hypertensive insulin-dependent diabetic men: a randomized cross-over study.
    Jenkins DA, Cowan P, Patrick AW, Clarke BF.
    Nephrol Dial Transplant; 1993 Aug; 8(3):200-5. PubMed ID: 8385284
    [Abstract] [Full Text] [Related]

  • 24. Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.
    Nielsen FS, Rossing P, Gall MA, Skøtt P, Smidt UM, Parving HH.
    Diabetes; 1997 Jul; 46(7):1182-8. PubMed ID: 9200654
    [Abstract] [Full Text] [Related]

  • 25. [The recovery of the kidney filtration functional reserve in diabetes mellitus patients on captopril treatment].
    Shestakova MV, Mukhin NA, Dedov II, Titov VN, Pomerantseva NV, Okunev DIu, Lipitskaia IIa.
    Ter Arkh; 1991 Jul; 63(6):50-5. PubMed ID: 1948747
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Low-protein diet and kidney function in insulin-dependent diabetic patients with diabetic nephropathy.
    Hansen HP, Christensen PK, Tauber-Lassen E, Klausen A, Jensen BR, Parving HH.
    Kidney Int; 1999 Feb; 55(2):621-8. PubMed ID: 9987086
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria. The Microalbuminuria Captopril Study Group.
    Diabetologia; 1996 May; 39(5):587-93. PubMed ID: 8739919
    [Abstract] [Full Text] [Related]

  • 31. The effects of angiotensin-converting enzyme inhibitors on the clinical and biochemical parameters in diabetic nephropathy.
    Gültekin F, Erdoğan GH, Ozersoy U, Alagözlü H.
    Ren Fail; 1993 May; 15(5):615-22. PubMed ID: 8290708
    [Abstract] [Full Text] [Related]

  • 32. Converting enzyme-inhibition in diabetic nephropathy.
    Mathiesen ER, Parving HH, Hommel E.
    Contrib Nephrol; 1989 May; 73():160-1; discussion 161-2. PubMed ID: 2689092
    [No Abstract] [Full Text] [Related]

  • 33. Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy.
    Parving HH, Andersen AR, Smidt UM, Svendsen PA.
    Lancet; 1983 May 28; 1(8335):1175-9. PubMed ID: 6133986
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Effect of intensive treatment on diabetic nephropathy in patients with type I diabetes.
    Manto A, Cotroneo P, Marra G, Magnani P, Tilli P, Greco AV, Ghirlanda G.
    Kidney Int; 1995 Jan 28; 47(1):231-5. PubMed ID: 7731151
    [Abstract] [Full Text] [Related]

  • 36. [Changes in blood pressure, proteinuria and renal hemodynamics in type I diabetes with manifestations of diabetic nephropathy after 2 months of captopril therapy].
    Komers R, Malý J, Simková R.
    Cas Lek Cesk; 1993 Jun 14; 132(12):359-64. PubMed ID: 8343943
    [Abstract] [Full Text] [Related]

  • 37. The course of kidney function in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy.
    Gall MA, Nielsen FS, Smidt UM, Parving HH.
    Diabetologia; 1993 Oct 14; 36(10):1071-8. PubMed ID: 8243857
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial.
    Bakris GL, Agarwal R, Chan JC, Cooper ME, Gansevoort RT, Haller H, Remuzzi G, Rossing P, Schmieder RE, Nowack C, Kolkhof P, Joseph A, Pieper A, Kimmeskamp-Kirschbaum N, Ruilope LM, Mineralocorticoid Receptor Antagonist Tolerability Study–Diabetic Nephropathy (ARTS-DN) Study Group.
    JAMA; 2015 Sep 01; 314(9):884-94. PubMed ID: 26325557
    [Abstract] [Full Text] [Related]

  • 40. Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively.
    Hovind P, Rossing P, Tarnow L, Smidt UM, Parving HH.
    Kidney Int; 2001 Jul 01; 60(1):277-83. PubMed ID: 11422762
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.